Editor: Jean-Marc Sabatier

Coronaviruses

Volume 2

eBook: US $49 Special Offer (PDF + Printed Copy): US $84
Printed Copy: US $59
Library License: US $196
ISSN: 2737-5625 (Print)
ISSN: 2737-5633 (Online)
ISBN: 978-981-4998-61-1 (Print)
ISBN: 978-981-4998-60-4 (Online)
Year of Publication: 2021
DOI: 10.2174/97898149986041210201

Introduction

Scientific literature on SARS-COV-2 viruses and its variants (especially variants of concern such as the ‘Delta variant’) and important cellular targets is crucial to help researchers, epidemiologists, virologists and clinicians around the globe to develop a new generation of safer and more effective vaccines, and other treatments to address COVID-19 disease. The accompanying damage to the many organs and tissues of SARS-Co-2-infected people also needs to be understood and researchers are using data to devise meaningful protocols for treating these symptoms. This second volume of Coronaviruses brings together more useful information about the prevention, vaccination, and chemotherapies for the potential treatment of coronavirus infections. The volume includes eight chapters: (1) Broad spectrum antivirals to combat COVID-19 The reality and challenges, (2) COVID-19: Preventive and protective control management strategies, (3) Plant-derived extracts and bioactive compounds against coronavirus progression: preventive effects, mechanistic aspects, and structures, (4) Gastroenteritis: symptoms and epidemiology of SARS-CoV-2, (5) The chronicles of coronavirus: A Chinese king who conquered the entire world, (6) Traditional medicine as a natural remedy in ARDS & COVID-19, (7) Molecular pathogenesis of human coronaviruses of the 21st century, (8) COVID-19, mental health and neuropathophysiology of pain related to temporomandibular disorder. The volume serves as a novel compilation of key data on SARS-CoV-2 and COVID-19 and represents a resource of the utmost value for all scholars studying SARS-CoV infections. It should also be of great interest to clinicians who may be facing an overwhelming number of individuals affected with COVID-19, with over 267 million global cases documented as of the first week of December 2021).

Audience: Researchers, epidemiologists, virologists and healthcare professionals interested in understanding COVID-19 and the virology of SARS-CoV-2.

Preface

In this still pandemic period of SARS-CoV-2 (and its variants, especially ‘Delta’ variant) infection that is responsible for Covid-19, the scientific literature on these viruses and related cellular targets is crucial to help the researchers/virologists and clinicians from all countries to develop a new generation of safer and more effective vaccines, as well as treatments to cure the more or less severe diseases and damages to the many organs and tissues of SARS-CoV- 2-infected people. This second book on coronaviruses mainly brings together some useful information regarding the prevention/vaccination, and chemotherapies to the potential treatment of coronavirus infections. The collection combines eight chapters titled: (1) Broad-spectrum antivirals to combat covid-19: The reality and challenges (chapter 1), (2) Covid-19: Preventive and protective control management strategies (chapter 2), (3) Plant-derived extracts and bioactive compounds against coronavirus progression: preventive effects, mechanistic aspects, and structures (chapter 3), (4) Gastroenteritis: symptoms and epidemiology of SARS-CoV-2 (chapter 4), (5) The chronicles of coronavirus: A Chinese king who conquered the entire world (chapter 5), (6) Traditional medicine as a natural remedy in ARDS & Covid-19 (chapter 6), (7) Molecular pathogenesis of human coronaviruses of 21st century (chapter 7), (8) COVID-19, mental health and neuropathophysiology of pain related to temporomandibular disorder (chapter 8).

Such a novel book compiling key data on SARS-CoV-2 and Covid-19 actually represents a tool of the utmost value for all researchers working on these research fields. It should also be of great interest to clinicians who are facing an overgrowing number of individuals with Covid-19. The data from 20th October 2021 give ca. 242 million cases of SARS-CoV-2 infection worldwide, with over 4.9 million deaths.



Jean-Marc Sabatier
Institute of NeuroPhysiopathology
Marseille, Cedex
France

RELATED BOOKS

.Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product.
.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.